We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Low-Calorie Cranberry Juice Shown to Lower Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 14 Jul 2015
Print article
Image: Cranberries grown and harvested in Massachusetts (USA). Cranberry juice was found to lower risk of developing cardiovascular disease (Photo courtesy of Wikimedia Commons).
Image: Cranberries grown and harvested in Massachusetts (USA). Cranberry juice was found to lower risk of developing cardiovascular disease (Photo courtesy of Wikimedia Commons).
Supplementing the diet with low-calorie cranberry juice (LCCJ) reduces the chances of developing cardiovascular disease by lowering several risk factors including circulating triglycerides (TGs), C-reactive protein (CRP), glucose, and diastolic blood pressure (BP).

Investigators at the United States Department of Agriculture (Beltsville, MD, USA) and Ocean Spray Cranberries, Inc. (Lakeville-Middleborough, MA, USA) conducted a double-blind, placebo-controlled, parallel-arm study on 30 women and 26 men. For eight weeks the participants ate controlled diets supplemented with twice daily drinks of 240 milliters of LCCJ or a placebo beverage, containing 173 or 62 mg of phenolic compounds and 6.5 or 7.5 g of total sugar per 240 milliliter serving, respectively.

Results published in the April 22, 2015, online edition of the Journal of Nutrition revealed that fasting serum TGs were lower after consuming LCCJ and that the participants with higher baseline TG concentrations were more likely to experience a larger treatment effect. Other cardiovascular disease risk factors including serum C-reactive protein (CRP), diastolic blood pressure (BP), and fasting plasma glucose were lower for individuals consuming LCCJ than for individuals consuming the placebo beverage. Furthermore, LCCJ had a beneficial effect on homeostasis model assessment of insulin resistance for participants with high baseline values.

"At the start and end of the experiment, the researchers measured things like blood pressure, blood sugar levels, blood lipids, as well as C-reactive protein, a marker of inflammation," said contributing author Dr. Christina Khoo, director of research sciences at Ocean Spray Cranberries, Inc. "All of these measurements come together to tell a story. The worse off these numbers are in an individual, the more likely he or she will face a health condition like diabetes, heart disease, or stroke in the future. These findings suggest that polyphenols help to protect our bodies, and may be adept at keeping a large number of ailments at bay. Luckily for us, a rich source of polyphenols is only a glass of cranberry juice away. Among the commonly consumed fruits in our diets, cranberries boast some of the highest levels of polyphenols—more than apples, blueberries, grapes, or cherries."

The investigators suggested that individuals drinking two glasses of LCCJ per day could experience up to a 10% percent lower risk of heart disease and a 15% percent lower risk of stroke.

Related Links:

United States Department of Agriculture
Ocean Spray Cranberries, Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.